Oceanic Bioactive Molecules And Marine Natural Products With Biopharmaceutical Potential | 26966
ISSN: 2155-9910

Journal of Marine Science: Research & Development
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Oceanic bioactive molecules and marine natural products with biopharmaceutical potential

3rd International Conference on Oceanography

George Schroeder

ScientificTracks Abstracts: J Marine Sci Res Dev

DOI: 10.4172/2155-9910.S1.010

The vast array of oceanic sources of bioactive molecules provides a new frontier in exploration and discovery. In blending a variety of ocean sciences, an innovative development of disciplines such as, proteomics, metabolomics, metagenomics as well as the study of a variety of oceanic derivatives of carbohydrate and lipid metabolism are yielding promising marine natural products. These are yielding remarkable potential in human, veterinary medicine, nutraceuticals and cosmeceuticals measurably contributing to enhancing the quality of life and perhaps even leading to considerable extension of longevity of the human life span while at the same time, reducing morbidity and disability resulting from chronic degenerative diseases and illnesses burdening terrestrial life forms. Phenomenal adaptive mechanisms by a wide variety of oceanic organisms including their marine toxins, of considerable greater potency arising from the significant biodiversity of oceanic life forms in comparison to land-based sources of natural products; provide enormous potential for exploration of bioactive molecules for biopharmaceutical development. Ocean-derived agrichemicals have already shown proven potential in optimizing and measurably augmenting crop yields for farmers. Oceanic sponges may lead to further procurement of bioactive molecules which shall deliver new and effective chemotherapeutic agents, anti-microbial, anti-inflammatories in treating a multitude of various forms of cancer as well as antiangiogenic effect in preventing metastatic spread of existing forms of cancer and thereby contributing to improved prognosis and extending survival for existing cancer patients. Marine natural products such as Triterpene glycosides derived from Sea Cucumbers are proving to be effective precursor bioactive molecules for a multitude of biomedical benefits including antimicrobial and especially potent anti-viral potential. It is therefore evident that marine natural products, delivering Oceanic Bioactive Molecules are a logical, current and future source of a vast array of promising new products for biomedical application. This is leading to an exciting new pioneering Era of scientific innovation in the new and fascinating biomedical disciplines of Infectious disease, Regenerative Medicine, Pandemic & Bioterrorism contingency planning, as well as stem-cell therapies, Many new Bio-markers in early disease detection and prevention, bio-engineering and 3-D printing among several new and exciting other technologies. This shall lead to enhanced repair as well as regeneration of new body parts, entirely new organs, human tissue damaged by disease, trauma, environmental exposure or even natural aging, associated with cost-prohibitive chronic degenerative illnesses. This Symposium at the Third International Conference of Oceanography shall delve into several of such fascinating subjects and thereby share information critical in the time-sensitive emergence of these burgeoning new subspecialties of oceanic and marine biomedical sciences.
George Schroeder is a graduate of the University of Toronto, Faculty of Medicine, Toronto, Ontario, Canada, in addition to having earned a M.S. in Healthcare Management from the University Of Texas School Of Graduate Management, affiliated with the South Western Medical School, Dallas, Texas. He is a member of the Beta Gama Sigma International Honor Society 2008. Currently he serves as Executive Director of Medical Affairs for the American Academy of Urgent Care Medicine, as well as a member of the Board of Directors of the American Board of Urgent Care Medicine. He is a Clinical Assistant Professor of Emergency Medicine at the University Of Central Florida College Of Medicine, in Orlando, Florida.